Heart Failure and Hospital Readmissions

Slides:



Advertisements
Similar presentations
Effect of Rapid Clinic Follow-Up After Hospital Discharge on 30- Day Heart Failure Readmission Lee Arcement, MD, MPH Dragana Lovre, MD.
Advertisements

Transitions of Care: From Hospital to SNF Steven Tam, MD Assistant Clinical Professor UCI Program in Geriatrics, Internal Medicine.
// High Tech, High Touch Health Care February 5, © 2015 Qualcomm Life. All rights reserved.
Discussant Inder Anand, MD, FRCP, D Phil (Oxon.)
©2011 Walgreen Co. All rights reserved. Georgia Hospital Association Reducing Readmission Learning Collaborative November 7, 2012.
Engaging the C-suite to Advance Pharmacy Practice Providing quality patient care through progressive pharmacy practice Safety, Quality, and the Pharmacy.
2 AMERIGROUP Community Care Entered Maryland market in 1999 Largest MCO in Maryland Serving over 143,000 members in Baltimore City and 20 counties in.
Medication Adherence in Heart Failure University of Central Florida Tessa Dillon.
HRET/K-HEN Readmissions Race Office Hour Building a Multidisciplinary Care Transitions Team January 25, 2013.
Collaboration for Improved Clinical Outcomes Patients’ Needs Vibra, ARU, SNFs, HHA, et al Clinical/Financial Stability and Patient/Resident/Client Satisfaction.
Post-discharge is a vulnerable phase for heart failure patients.
Hospital Value-Based Purchasing Update Jim Poyer Director, OCSQ/QIG/DQIPAC April 27, 2011.
From Knowledge to Practice Translation A Multidisciplinary Intervention to Reduce 30 day Heart Failure Readmissions.
Bundled Payments for Care Improvement (BPCI) Alliance for Health Reform Capitol Hill Briefing Jim Garnham Dir. Contracting & Payment Innovation.
The CHART-2 Study (The Chronic Heart Failure Analysis and Registry in the Tohoku District 2) Source Shiba N, Nochioka K, Miura M, et al. Trend of westernization.
A Statewide Collaborative Initiative to Improve the Quality of Care for Patients With Acute Myocardial Infarction and Heart Failure Circulation. 2009;119:
Characteristics of Health Activation Solutions
DIAGNOSIS No symptoms = no heart failure. DIAGNOSIS No symptoms = no heart failure.
Grand-Aides: Transitional/ Chronic Care Management S
Interdisciplinary Team Role Play
Copyright © 2007 American Medical Association. All rights reserved.
CLINICAL DILEMMAS IN HEART FAILURE:
Emerging Concepts in Heart Failure
Hospitalizations and Healthcare Costs Need for Reduction in Hospitalizations of Patients With HF
Using the SafeMed model for transitions of care approach
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons From Clinical Trials.
Acute Heart Failure.
Heart Rate, HF Admissions, and Readmissions
Biomarkers in Heart Failure
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.
Select Topics in Cardiovascular Medicine
Medication Nonadherence in Gout
Patient Presentation Patient’s Changing Condition Multiple Considerations To Balance.
Cost Effectiveness and Optimal Outcomes in HF
Global Burden of VTE. Preventing Thrombosis During and Post-Hospitalization: New Paradigms in Clinical Care.
Adverse Neurohormonal Activation in HF Has Formed the Basis for Evidence-Based Pharmacologic Therapy
Using the SafeMed model for transitions of care approach
Heart Failure Management Coordinated Care Approaches
Heart Failure Prevention: Mission Impossible?
Preventing Heart Failure Readmission and Progression
Biomarker-Guided HF Therapy: Is It Cost-Effective?
Evaluating New Therapies in HF
SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.
The Importance of Getting the Dose Right in HF
Using Heart Rate as a Biomarker in Clinical Practice.
QUALITY: COORDINATED CARE
Learning Objectives CMS Measures in HF: 30-day Hospital Readmission Rates.
Updates in Heart Failure:
Revisiting the Pharmacoeconomics of HF
Improving 30-Day HF Readmission Rates With Biomarker-Guided Therapy
Assessing Atrial Fibrillation: Real-World Data vs Clinical Trials
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.
Challenging the Myths in Heart Failure With Reduced Ejection Fraction
New Strategies to Reduce HF Readmissions
[Hospital/Facility Name/Logo]
Transitional Care of Patients With Hepatic Encephalopathy
A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.
Improving Adherence to Antiplatelet Therapy After an ACS Event
Hospital Value-Based Purchasing Update Jim Poyer
HF-Related Hospitalization and Readmissions
TRUE-AHF Trial design: Patients with acute decompensated heart failure were randomized in a 1:1 fashion to either early ularitide infusion (within 12 hours)
GUARANTEE OF CARE: What is acceptable readmission Ilkka Vohlonen, Professor Health Policy Eastern Finland University Casemix Conference Helsinki,
Heart Failure Currently, an estimated 5.7 million Americans are living with heart failure. An additional 670,000 new cases are diagnosed annually, up.
Uptitration of Medications in HF: Start Low but Aim High and Stay High
In-Hospital Treatment for Heart Failure: New Approaches and a Renewed Sense of Hope?
My PAH Patient.
Top Tips in Evidence-Based Care for HFrEF
Key Data on Improving Outcomes in HF Patients
QUALITY: COORDINATED CARE
What Do the Guidelines Say About The Role of the HF Nurse?
Presentation transcript:

Heart Failure and Hospital Readmissions

Causes of Hospital Readmission for HF

Acute Heart Failure Patient Characteristics

Major Comorbidities in Hospitalized Patients With AHF OPTIMIZE-HF Registry

HF Rehospitalization and Mortality Rates

Repeated Hospitalizations Predict Mortality

Cost of Heart Failure to Society

A Large Number of Eligible Patients Are Untreated

Always Consider Titration

New Therapies in HF

New Targets / Trials (Looking at HF from different angles)

PARADIGM-HF Design

PARADIGM-HF (Sacubitril/Valsartan) Results

Effect of Ivabradine on Outcomes

Hospitalizations and Healthcare Costs -- Need for Reduction in Hospitalizations of HF Patients

Hospitalization = Disease Changes

How to Best Transition Care?

Elements of Optimal Transition of Care 2015 AHA Scientific Statement

Medicare 30-Day Readmission Penalty

The Rule

Shouldn't It Work?

Understanding Health Care As a System

Transitions of Care Beyond the Front Door Wishful Thinking vs Reality

Identify The Vulnerable Patient

Typical List of Meds BB Clinic

Brown Bag Clinic Better Adherence Methods

Looking Back – What Happened in the Hospital?

Navigating the Inpatient Landscape

Inpatient Care

Medication Nonadherence

Diet Nonadherence

Post Discharge Care

There Need to be Links!

Summary -- Take Home Pointers

Abbreviations

Abbreviations